Search Results - "Dyke, C K"

Role of nitric oxide in exercise hyperaemia during prolonged rhythmic handgripping in humans by Dyke, C K, Proctor, D N, Dietz, N M, Joyner, M J

“…1. We sought to determine whether the vasodilating molecule nitric oxide (NO) contributes to the forearm hyperaemia observed during prolonged rhythmic…”
Get full text

First experience with direct, selective factor Xa inhibition in patients with non‐ST‐elevation acute coronary syndromes: results of the XaNADU‐ACS Trial by ALEXANDER, J. H., YANG, H., BECKER, R. C., KODAMA, K., GOODMAN, S., DYKE, C. K., KLEIMAN, N. S., HOCHMAN, J. S., BERGER, P. B., COHEN, E. A., LINCOFF, A. M., BURTON, J. R., BOVILL, E. G., KAWAI, C., ARMSTRONG, P. W., HARRINGTON, R. A.

“…Background: Unfractionated heparin is widely used in patients with non‐ST‐elevation acute coronary syndromes but has important limitations. Anticoagulants with…”
Get full text

Initial experience with factor‐Xa inhibition in percutaneous coronary intervention: the XaNADU‐PCI Pilot by Alexander, J. H., Dyke, C. K., Yang, H., Becker, R. C., Hasselblad, V., Zillman, L. A., Kleiman, N. S., Hochman, J. S., Berger, P. B., Cohen, E. A., Lincoff, A. M., Saint‐Jacques, H., Chetcuti, S., Burton, J. R., Buergler, J. M., Spence, F. P., Shimoto, Y., Robertson, T. L., Kunitada, S., Bovill, E. G., Armstrong, P. W., Harrington, R. A.

“…Background: Direct factor (F)Xa inhibition is an attractive method to limit thrombotic complications during percutaneous coronary intervention (PCI)…”
Get full text

Effect of skeletal muscle fiber type on the pressor response evoked by static contraction in rabbits by Wilson, L B, Dyke, C K, Parsons, D, Wall, P T, Pawelczyk, J A, Williams, R S, Mitchell, J H

“…The purpose of this study was to determine whether the reflex hemodynamic responses to static contraction of predominately glycolytic muscle are greater than…”
Get more information

National and regional registries: what good are they? by Dyke, C.K., Calif, R.M.

Get full text

Forearm blood flow responses to handgripping after local neuromuscular blockade by Dyke, Christopher K, Dietz, Niki M, Lennon, Robert L, Warner, David O, Joyner, Michael J

“…Department of Anesthesiology, Mayo Clinic and Foundation, Rochester, Minnesota 55905; and Department of Internal Medicine, University of Texas Southwestern…”
Get full text

Cardiovascular and renal nerve responses to static muscle contraction of decerebrate rabbits by Wilson, L B, Dyke, C K, Pawelczyk, J A, Wall, P T, Mitchell, J H

“…The purpose of this study was to determine whether the biphasic arterial blood pressure responses elicited by static muscle contraction of decerebrate rabbits…”
Get more information

The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy by Blazing, Michael A., de Lemos, James A., Dyke, Christopher K., Califf, Robert M., Bilheimer, David, Braunwald, Eugene

“…Background The A-to-Z Trial is an ongoing international, multicenter, randomized study designed to investigate 2 issues concerning contemporary care of…”
Get full text

Highlights from the American College of Cardiology 49th Annual Scientific Sessions: March 12 to 15, 2000 by McGuire, Darren K., O’Shea, J.Conor, Dyke, Christopher K., Kandzari, David E., East, Mark A., Tolleson, Thaddeus R.

Get full text

Prognosis of Negative Adenosine Stress Magnetic Resonance in Patients Presenting to an Emergency Department With Chest Pain by Ingkanisorn, W. Patricia, Kwong, Raymond Y., Bohme, Nicole S., Geller, Nancy L., Rhoads, Kenneth L., Dyke, Christopher K., Paterson, D. Ian, Syed, Mushabbar A., Aletras, Anthony H., Arai, Andrew E.

“…Prognosis of Negative Adenosine Stress Magnetic Resonance in Patients Presenting to an Emergency Department With Chest Pain W. Patricia Ingkanisorn, Raymond Y…”
Get full text

Artifact suppression in imaging of myocardial infarction using B sub(1)- weighted phased-array combined phase-sensitive inversion recovery by Kellman, P, Dyke, C K, Aletras, AH, McVeigh, E R, Arai, A E

“…Regions of the body with long T sub(1), such as cerebrospinal fluid (CSF), may create ghost artifacts on gadolinium-hyperenhanced images of myocardial…”
Get full text

First experience with direct factor Xa inhibition in patients with stable coronary disease: A pharmacokinetic and pharmacodynamic evaluation by DYKE, Christopher K, BECKER, Richard C, ZILLMAN, Linda A, SHIMOTO, Yoshimasa, ROBERTSON, Thomas L, KUNITADA, Satoshi, ARMSTRONG, Paul W, HARRINGTON, Robert A, KLEIMAN, Neal S, HOCHMAN, Judith S, BOVILL, Edwin G, LINCOFF, A. Michael, GERSTENBLITH, Gary, DZAVIK, Vladimir, GARDNER, Laura H, HASSELBLAD, Vic

“…Thrombin generation is critical to the formation of an arterial thrombus after rupture of an atherosclerotic plaque. In patients with stable coronary disease…”
Get full text

Highlights from the XXII Congress of the European Society of Cardiology: August 26 to 30, 2000 by McGuire, Darren K., O’Shea, J.Conor, Dyke, Christopher K., Velazquez, Eric J., Hudson, Michael P.

Get full text

Misreporting of myocardial infarction end points: Results of adjudication by a central clinical events committee in the PARAGON-B trial by Mahaffey, Kenneth W., Roe, Matthew T., Dyke, Christopher K., Newby, L.Kristin, Kleiman, Neal S., Connolly, Patty, Berdan, Lisa G., Sparapani, Rodney, Lee, Kerry L., Armstrong, Paul W., Topol, Eric J., Califf, Robert M., Harrington, Robert A.

“…Background Myocardial (re)infarction (MI), a common trial end point, can be difficult to identify because of inconclusive signs and symptoms. We examined…”
Get full text

Artifact suppression in imaging of myocardial infarction using B 1 ‐weighted phased‐array combined phase‐sensitive inversion recovery by Kellman, Peter, Dyke, Christopher K., Aletras, Anthony H., McVeigh, Elliot R., Arai, Andrew E.

“…Abstract Regions of the body with long T 1 , such as cerebrospinal fluid (CSF), may create ghost artifacts on gadolinium‐hyperenhanced images of myocardial…”
Get full text

Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular disease by Becker, Richard C, Alexander, John, Dyke, Christopher K, Harrington, Robert A

“…The development of anticoagulants for treating patients with atherothrombotic disorders of the arterial circulatory system has focused, either directly or…”
Get more information

Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonist by Becker, Richard C, Alexander, John, Li, You Fu, Bovill, Edwin, Spencer, Frederick A, Robertson, Thomas L, Kunitada, Satoshi, Dyke, Christopher K, Harrington, Robert A

Get more information

Highlights from the American College of Cardiology 50th Annual Scientific Sessions: March 18 to 21, 2001

Get full text

Highlights from the American College of Cardiology Forty-Ninth Annual Scientific Sessions: March 18 to 21, 2001 by Bahit, Maria Cecilia, Cabell, Christopher H., Dyke, Christopher K., Felker, G.Michael, Kaul, Padma, McGuire, Darren K., O'Shea, J.Conor, Reddan, Donal, East, Mark

Get full text